These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 27396504)
1. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700]. Jadhav GR; Sinha S; Chhabra M; Paira P Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504 [No Abstract] [Full Text] [Related]
2. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431]. Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309 [No Abstract] [Full Text] [Related]
3. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870]. Arslan T; Türkoğlu EA; Şentürk M; Supuran CT Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642 [No Abstract] [Full Text] [Related]
4. Corrigendum to "A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus" [Bioorg. Med. Chem. Lett. 27 (2017) 893-896]. Zhou J; Feng JH; Robertson J; Fang L Bioorg Med Chem Lett; 2020 Aug; 30(16):127294. PubMed ID: 32518059 [No Abstract] [Full Text] [Related]
5. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057]. Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140 [No Abstract] [Full Text] [Related]
6. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369]. Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444 [No Abstract] [Full Text] [Related]
7. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484]. Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958 [No Abstract] [Full Text] [Related]
8. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]". Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037 [No Abstract] [Full Text] [Related]
9. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390]. Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987 [No Abstract] [Full Text] [Related]
10. Corrigendum to "Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities" [Bioorg. Med. Chem. Lett. 20(23) (2010) 7110-7115]. Liang C; Ding Y; Nguyen HT; Kim JA; Boo HJ; Kang HK; Nguyen MC; Kim YH Bioorg Med Chem Lett; 2021 Jun; 41():128014. PubMed ID: 33867227 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369]. Abdelall EKA; Abdelhamid AO; Azouz AA Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977 [No Abstract] [Full Text] [Related]
12. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097]. Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066]. Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668 [No Abstract] [Full Text] [Related]
14. Corrigendum to "Solid-phase synthesis of Biotin-S-Farnesyl-l-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT)" [Bioorg. Med. Chem. Lett. 23 (2013) [5671-5673]. Stevenson GI; Yong S; Fechner GA; Neve J; Lock A; Avery VM Bioorg Med Chem Lett; 2018 Aug; 28(14):2575. PubMed ID: 30007572 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606]. Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163 [No Abstract] [Full Text] [Related]
16. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587]. Yin J; Zhao Y; He Q; Hai A; Peng Y; Zuo Z; Gao L; Song Z; Ke B Bioorg Med Chem Lett; 2022 Jul; 68():128765. PubMed ID: 35525630 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998]. Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326 [No Abstract] [Full Text] [Related]
19. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535]. Hartung AM; Navarro HA; Wiemer DF; Neighbors JD Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96]. Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641 [No Abstract] [Full Text] [Related] [Next] [New Search]